Clinical Trials on Relapsed AML in Peru
Total 2023 results
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Cryptococcal MeningitisKenya, Thailand, Uganda, United States, Peru, South Africa, Zimbabwe, India
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
National Institute of Allergy and Infectious Diseases...Bill and Melinda Gates FoundationCompletedHIV InfectionsUnited States, Brazil, Ecuador, Peru, South Africa, Thailand
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionPeru, Kenya, Malawi, Brazil, South Africa, Zimbabwe, India, Thailand, Tanzania
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States, Australia, Peru, Puerto Rico
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Hoffmann-La RocheCompletedAnemiaMexico, Colombia, Argentina, Venezuela, Brazil, Uruguay, Ecuador, Peru, Chile
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
NovartisCompletedOpen Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderBipolar DisorderAustria, Canada, Czech Republic, Germany, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela, United States, Colombia, Guatemala
-
Novartis PharmaceuticalsCompletedBipolar DisorderUnited States, Austria, Canada, Colombia, Czech Republic, Germany, Guatemala, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedBipolar DisorderUnited States, Mexico, Peru, South Africa, Russian Federation, Croatia, Bulgaria
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | OsteoporosisFrance, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
-
Partners in HealthHarvard Medical School (HMS and HSDM); Epicentre; Interactive Research and Development and other collaboratorsCompletedTuberculosis, Multidrug-ResistantGeorgia, Armenia, Bangladesh, Belarus, Ethiopia, Indonesia, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Myanmar, Pakistan, Peru, South Africa
-
SciClone PharmaceuticalsTerminatedPancreatic CancerUnited States, Chile, Spain, Brazil, Argentina, France, Germany, Hungary, Netherlands, Peru, Poland, Romania, United Kingdom
-
AstraZenecaCompletedPostoperative or Postradiation Adjuvant Androgen Deprivation Therapy in Locally Advanced Prostate Cancer (High and Very High Risk) PatientsRussian Federation
-
AbbVieCompletedChronic Hepatitis C (CHC)Russian Federation
-
Janssen Pharmaceutica N.V., BelgiumCompletedBipolar DisorderChina, Taiwan, Colombia, India, Malaysia, Russian Federation, South Africa, Greece, Peru, Germany, Mexico, Lebanon, Indonesia, Philippines, Jordan
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
GlaxoSmithKlineCompletedImpetigoIndia, Mexico, Netherlands, Italy, Peru
-
Janssen Infectious Diseases BVBACompletedTuberculosisSouth Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
-
Novartis PharmaceuticalsCompletedThrombocytopaeniaBelgium, Greece, Netherlands, Romania, China, Korea, Republic of, Tunisia, France, Hong Kong, Ireland, Peru, Poland
-
GlaxoSmithKlineCompletedNeoplasms, BreastFrance, Belgium, Peru, Italy, Colombia
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
Berlin-Chemie AG Menarini GroupCompletedDeep Vein ThrombosisGeorgia, Russian Federation
-
NPO PetrovaxCompletedFibrosis | Lung Diseases, Interstitial | Lung; Disease, Interstitial, With Fibrosis | Post-Acute COVID-19 Syndrome | Lung Disease With PolymyositisRussian Federation
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedAnemia | Lung Cancer | Neutropenia | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
International Atomic Energy AgencyCompletedCervix CancerPeru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom
-
Fulcrum TherapeuticsTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Cancer | Radiation Toxicity | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Materia Medica HoldingCompletedAcute Respiratory Viral InfectionRussian Federation
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
AstraZenecaRecruitingNon-small-cell Lung CancerRussian Federation
-
Materia Medica HoldingCompletedInfluenza and Acute Respiratory Viral InfectionsRussian Federation, Belarus, Ukraine
-
UCB PharmaTerminatedRheumatoid Arthritis | Crohn's DiseaseRussian Federation
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, Argentina
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultidrug-resistant TuberculosisSouth Africa, Estonia, Philippines, Peru, Lithuania, Latvia, Moldova, Republic of
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingCigarette Smoking-Related CarcinomaUnited States
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
AstraZenecaCompletedDepression | Bipolar Disorder | Bipolar DepressionUnited States, Peru, South Africa, Turkey, Romania, Australia, Chile, Greece, Mexico, Colombia, Costa Rica
-
MedImmune LLCAstraZenecaTerminatedLupus Erythematosus, SystemicUnited States, Mexico, Peru, South Africa, Canada
-
Materia Medica HoldingRecruitingPneumonia | Community-acquired PneumoniaRussian Federation
-
Carmen Gómez-VaqueroTerminated
-
HilleVaxActive, not recruitingGastroenteritisDominican Republic, United States, Peru, Colombia, Honduras, Panama, Puerto Rico